semaglutide cardiovascular trial news SELECT Cardiovascular Outcomes, Safety, and Tolerability

For example, testosterone replacement therapy combined with BPC-157 for injury recovery and CJC-1295 for anti-aging

And then there are small molecule non peptide

And we have dozens and dozens of these phase three drug trials

Beyond weight loss, semaglutide has demonstrated cardiovascular benefits in the SELECT trial, showing a 20 percent reduction in major cardiovascular events in overweight and obese patients with established cardiovascular disease

15, 30 June 2025, 100188, Pich, Marie-Eve, Andr Tchernof, and Jean-Pierre Desprs

Your provider can evaluate for underlying causes requiring treatment, run bloodwork to check for deficiencies or metabolic issues, adjust your semaglutide dose if needed, and provide additional support and strategies